CSIMarket
 

Global Cord Blood Corp  (CO)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Global Cord Blood's Working Capital Per Sales

CO's Working Capital and Revenue growth



CO Working Capital Per Revenue (Mar 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Mar 31 2021)
IV. Quarter
Y / Y Working Capital Change 20.3 % 20.3 % 20.3 % 20.3 % 6.09 %
Y / Y Revenue Change 10.8 % - - - 2.6 %
Working Capital Per Revenue 4.41 4.68 4.48 4.27 4.07
Total Ranking # 3836 # 3793 # 3809 # 3831 # 2805
Seq. Working Capital Change 0 % 0 % 0 % 20.3 % 0 %
Seq. Revenue Change - - - - -





Comment on CO's Working Capital Per Revenue in the fourth quarter 2022
Global Cord Blood's Working Capital Per Revenue in the Q4 2022 sequentially fell to 4.41 but remained above Global Cord Blood's average.

Within Healthcare sector 71 other companies have achieved lower Working Capital Per Revenue during the Q4 2022. While Working Capital Per Revenue total ranking has deteriorated in the fourth quarter 2022, compared to previous quarter from 3793 to 3836.
Working Capital Per Revenue Ranking
Within: No.
Industry # 16
Sector # 72
S&P 500 # 3836


Working Capital Per Revenue Statistics
High Average Low
4.89
4.1
2.93
(Mar 31 2021)   (Mar 31 2017)



Financial Statements
Global Cord Blood's Working Capital $ 866 Millions Visit CO's Balance sheet
Global Cord Blood's Revenues $ 196 Millions Visit CO's Income Statement
Where are CO's Sales coming from? Visit CO's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2022, within Healthcare Sector Working Capital Per Revenue
Curis Inc   11.87 
Biocardia Inc  11.56 
Old Ayala Inc   11.49 
Kala Bio inc   11.23 
Atara Biotherapeutics Inc   11.19 
Zymeworks Inc   10.91 
One World Products Inc   10.86 
Xenetic Biosciences Inc   10.78 
Gritstone Bio Inc   10.76 
Fulcrum Therapeutics Inc   10.61 
Cyclerion Therapeutics Inc   10.48 
Helius Medical Technologies inc   10.43 
Denali Therapeutics Inc   10.43 
Baudax Bio Inc   10.22 
Pulmatrix Inc   10.04 
Cytek Biosciences Inc   9.94 
Sigilon Therapeutics Inc   9.92 
Novan Inc   9.88 
Zosano Pharma Corporation  9.60 
Bridgebio Pharma Inc   9.47 
Fate Therapeutics Inc   9.04 
Finch Therapeutics Group Inc   8.94 
Abvc Biopharma Inc   8.67 
G1 Therapeutics Inc   8.65 
Anaptysbio Inc   8.38 
Spectral Ai Inc   8.31 
Cyclo Therapeutics Inc   8.30 
Zai Lab Limited  8.29 
Ispecimen inc   8.17 
Eiger Biopharmaceuticals Inc   8.15 
Date modified: 2022-08-18T06:35:43+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com